![John Schmid](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Schmid
Directeur/Membre du Conseil chez
ANAPTYSBIO, INC.
Fortune : 4 M $ au 30/06/2026
Profil
John P.
Schmid was the founder of GeneFormatics, Inc., founded in 1998, where the title held was Chief Financial Officer from 1998 to 2003.
Mr. Schmid was the founder of Trius Therapeutics, Inc., founded in 2004, where the title held was Chief Financial Officer & Secretary from 2004 to 2013.
Current jobs include Chairman at Speak, Inc. since 2013; Independent Director at AnaptysBio, Inc. since 2015; Director at Bright Peak Therapeutics, Inc. starting 2025; Independent Director at Design Therapeutics, Inc. since 2020; Independent Director at First Tracks Biotherapeutics, Inc.; Independent Director at Helix Acquisition Corp.
III; and Independent Director at Blossomhill Therapeutics, Inc. starting 2026.
Former jobs include Independent Non-Executive Director at Xeris Pharmaceuticals, Inc. from 2017 to 2021; Director at Patara Pharma LLC from 2016 to 2018; Director at Forge Therapeutics, Inc. from 2017 to 2024; Independent Non-Executive Director at Xeris Biopharma Holdings, Inc. from 2021 to 2025; Independent Director at Neos Therapeutics, Inc. from 2015 to 2021; President & Director at San Diego Venture Group from 1994 to 2005; Independent Director at Helix Acquisition Corp.
from 2020 to 2022; Independent Director at Poseida Therapeutics, Inc. from 2018 to 2025; Independent Director at Helix Acquisition Corp.
II; Associate at Idanta Partners Ltd. in 1995; Chief Financial Officer at Cengent Therapeutics, Inc.; Chief Financial Officer at Allylix, Inc.; Vice President at Indiana Bank & Trust Co.; Chief Financial Officer at Endonetics, Inc. from 1995 to 1998; Chief Financial Officer at Auspex Pharmaceuticals, Inc. from 2013 to 2015; Chief Financial Officer at Vessix Vascular, Inc.; Vice President at Home Federal Bank (Nampa, Idaho) from 1987 to 1992.
Education includes an MBA degree from the University of San Diego conferred in 1992 and an undergraduate degree from Wesleyan University conferred in 1985.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ANAPTYSBIO, INC. 0,13% | 15/06/2026 | 37 652 ( 0,13% ) | 3 M $ | 30/06/2026 |
| 09/06/2026 | 57 639 ( 0,09% ) | 834 036 $ | 30/06/2026 | |
0,11% | 15/06/2026 | 37 652 ( 0,11% ) | 757 558 $ | 30/06/2026 |
0,7% | 23/01/2026 | 30 000 ( 0,7% ) | 319 200 $ | 30/06/2026 |
Postes actifs de John Schmid
| Sociétés | Poste | Début |
|---|---|---|
| ANAPTYSBIO, INC. | Directeur/Membre du Conseil | 30/06/2015 |
| DESIGN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/11/2020 |
Bright Peak Therapeutics, Inc.
 Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for the treatment of cancer and autoimmune diseases | Directeur/Membre du Conseil | 01/03/2025 |
Speak, Inc.
 Speak, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as speaker bureau | Président | 21/12/2013 |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Directeur/Membre du Conseil | 01/05/2026 |
Anciens postes connus de John Schmid
| Sociétés | Poste | Fin |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Directeur/Membre du Conseil | 04/06/2025 |
| POSEIDA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 08/01/2025 |
Forge Therapeutics, Inc.
 Forge Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 01/04/2024 |
| HELX ACQU | Directeur/Membre du Conseil | 01/04/2022 |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de John Schmid
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
25
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 25 |
|---|---|
Idanta Partners Ltd.
 Idanta Partners Ltd. Investment ManagersFinance Idanta Partners invests in companies located in the US. The firm focuses on sectors such as healthcare, Internet technology and retail companies. It participates in seed and early stage capital requirements. | Finance |
Cengent Therapeutics, Inc.
 Cengent Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches & develops pharmaceutical drugs | Commercial Services |
Allylix, Inc.
 Allylix, Inc. Pharmaceuticals: OtherHealth Technology Develops terpene products and their derivatives | Health Technology |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
Patara Pharma LLC
 Patara Pharma LLC Pharmaceuticals: MajorHealth Technology Provides biotechnology solutions | Health Technology |
Indiana Bank & Trust Co.
 Indiana Bank & Trust Co. Regional BanksFinance State chartered commercial bank | Finance |
Endonetics, Inc.
 Endonetics, Inc. Medical SpecialtiesHealth Technology Develops technologies for the diagnosis and treatment of gastroesophageal reflux disease | Health Technology |
GeneFormatics, Inc.
 GeneFormatics, Inc. BiotechnologyHealth Technology Provides protein function determination | Health Technology |
University of San Diego
 University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wesleyan University
 Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets central nervous system-focused products | Health Technology |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
San Diego Venture Group
 San Diego Venture Group Financial ConglomeratesFinance Provides funding for start up companies | Finance |
Auspex Pharmaceuticals, Inc.
 Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Vessix Vascular, Inc.
 Vessix Vascular, Inc. Pharmaceuticals: OtherHealth Technology Develops products to treat artery disease | Health Technology |
Home Federal Bank (Nampa, Idaho)
 Home Federal Bank (Nampa, Idaho) Major BanksFinance Provides commercial banking services | Finance |
Speak, Inc.
Speak, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as speaker bureau | Commercial Services |
Poseida Therapeutics, Inc.
 Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Forge Therapeutics, Inc.
Forge Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Design Therapeutics, Inc.
 Design Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops therapies for serious degenerative disorders | Health Technology |
Helix Acquisition Corp.
 Helix Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
Bright Peak Therapeutics, Inc.
Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for the treatment of cancer and autoimmune diseases | Health Technology |
Xeris Biopharma Holdings, Inc.
 Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
